← Portfolio Scout

Portfolio company

Envisagenics

United States

Raised

Undisclosed

Latest stage

Series B

Rounds recorded

2 · 2 undisclosed

Backed by

2 investors

Sectors

Deep TechB2B SaaSDigital Health

About

This biotechnology company develops an artificial intelligence platform to identify drug targets from RNA splicing data for pharmaceutical and biopharmaceutical organisations.

Source

Funding history · 2

Similar companies